The world’s smallest defibrillation lead. Built for high reliability.
Introducing OmniaSecure™ defibrillation lead
Built on the proven SelectSecure™ 3830 pacing lead platform,1,2 the OmniaSecure™ defibrillation lead is catheter-delivered to enable targeted lead placement — giving physicians the opportunity to reimagine what’s next in reliable therapy delivery.1
The next era of electrophysiology
It takes an integrated, intricate, and indispensable network to make a heart beat. At Medtronic, we take our cues from biology itself. Only by working together can the body and the research and the technology move forward.
Restore
normal physiology
Restoring the normal physiology of our patients’ hearts with synchronized solutions and extensive evidence
Revolutionize
our patients’ experience
Revolutionizing our patients’ experience with therapies designed to be efficient, convenient, and accessible
Reimagine
what’s next
Reimagining what’s next through the power of AI, advanced algorithms, and transformed clinical workflows
We are unified in our mission to drive forward into the next era of electrophysiology.
Therapies and procedures
Products
- Crossley GH III, Sanders P, Hansky B, et al. Safety, efficacy, and reliability evaluation of a novel small-diameter defibrillation lead: Global LEADR pivotal trial results. Heart Rhythm. 2024;21(10):1914–1922. doi:10.1016/j.hrthm.2024.04.067.
- Crossley GH, Sanders P, Filippo P, et al. Rationale and design of the lead evaluation for defibrillation and Reliability study: Safety and efficacy of a novel ICD lead design. J Cardiovasc Electrophysiol. 2023;34(2):257–267. doi:10.1111/jce.15747.
- ICM publications. Medtronic data on file. 2021.